Tag Archives: SGMO

Thursday’s Highlights at Noon: Kandi Technologies (KNDI), MobileIron (MOBL), Sangamo Biosciences (SGMO), Dynavax (DVAX), uniQure (QURE)

So far Thursday, July 30, NASDAQ is up 5.66% and the S&P is up 1.5%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Kandi Technologies (KNDI – Research Report), MobileIron (MOBL – Research

Sunday’s Midday Stock Update: Celldex (CLDX), Chesapeake Energy (CHK), Omega Healthcare (OHI), Sangamo Biosciences (SGMO), Marathon Petroleum (MPC)

So far Sunday, June 21, NASDAQ is down -5.57% and the S&P is down -5.53%. Here are this morning’s most active stocks: Celldex (CLDX – Research Report), Chesapeake Energy (CHK – Research Report), Omega Healthcare (OHI – Research Report), Sangamo

A Director at Sangamo Biosciences (NASDAQ: SGMO) is Buying Shares

Yesterday, a Director at Sangamo Biosciences (SGMO – Research Report), Stewart Parker, bought shares of SGMO for $15.57K. Following this transaction Stewart Parker’s holding in the company was increased by 30% to a total of $72.28K. In addition to Stewart

Cowen & Co. Maintains Their Buy Rating on Sangamo Biosciences (SGMO)

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report) today. The company’s shares closed last Monday at $8.32. According to TipRanks.com, Baral is a 5-star analyst with an average return of 17.7%

H.C. Wainwright Reaffirms Their Buy Rating on Sangamo Biosciences (SGMO)

H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on Sangamo Biosciences (SGMO – Research Report) today and set a price target of $16.00. The company’s shares closed last Monday at $8.53. According to TipRanks.com, Chattopadhyay is a 3-star analyst

Saturday’s Highlights at Noon: Exelixis (EXEL), Mallinckrodt (MNK), Stratasys (SSYS), Sangamo Biosciences (SGMO), Karyopharm Therapeutics (KPTI)

So far Saturday, January 25, NASDAQ is down -5.75% and the S&P is down -3.67%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Exelixis (EXEL – Research Report), Mallinckrodt (MNK – Research Report),